Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy

At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic germline genetic variant (hereditary cancer syndrome—HCS). These individuals are burdened with lifelong surveillance monitoring organs for a wide spectrum of cancers. This is associated with substantial uncert...

Descripción completa

Detalles Bibliográficos
Autores principales: Farncombe, Kirsten M., Wong, Derek, Norman, Maia L., Oldfield, Leslie E., Sobotka, Julia A., Basik, Mark, Bombard, Yvonne, Carile, Victoria, Dawson, Lesa, Foulkes, William D., Malkin, David, Karsan, Aly, Parkin, Patricia, Penney, Lynette S., Pollett, Aaron, Schrader, Kasmintan A., Pugh, Trevor J., Kim, Raymond H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577078/
https://www.ncbi.nlm.nih.gov/pubmed/37802042
http://dx.doi.org/10.1016/j.ajhg.2023.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577078/
https://www.ncbi.nlm.nih.gov/pubmed/37802042
http://dx.doi.org/10.1016/j.ajhg.2023.08.014

Ejemplares similares